Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir-based 1st, 2nd or 3rd Line Regimens: the International Epidemiological Databases to Evaluate AIDS (IeDEA)

NCT06285110 is registered in ClinicalTrials.gov with University of Bern as lead sponsor.

NCT NCT06285110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06285110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir-based 1st, 2nd or 3rd Line Regimens: the International Epidemiological Databases to Evaluate AIDS (IeDEA)
Lead sponsor
University of Bern
Phase
Observational
Overall status
Completed
Start date
June 13, 2022
Completion date
August 31, 2025
Enrollment
1,103 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

hiv